Akari Therapeutics stock forecast
Akari Therapeutics (CLA1) Stock Forecast & Price Target
CLA1 Analyst Ratings
CLA1 Stock 12 Month Forecast
Average Price Target
€22.87▲(37389.34% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Sean Lee CFA | H.C. Wainwright | €24.21 | buy | 39594.60%Upside | Reiterated | 10/01/26 | ||
| Matthew Venezia | Alliance Global Partners | €6.28→€17.49 | buy | 28568.32%Upside | Reiterated | 09/16/26 | ||
| Jason McCarthy | Maxim Group | €26.90 | buy | 44005.11%Upside | Reiterated | 08/18/26 | ||
| Aydin Huseynov | Ladenburg Thalmann & Co. | €35.87 | buy | 58706.81%Upside | Initiated | 01/05/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Sean Lee CFAH.C. Wainwright | BuyReiterated€24.21 | 10/01/26 | 39594.60%Upside | ||
| Matthew VeneziaAlliance Global Partners | BuyReiterated€6.28→€17.49 | 09/16/26 | 28568.32%Upside | ||
| Jason McCarthyMaxim Group | BuyReiterated€26.90 | 08/18/26 | 44005.11%Upside | ||
| Aydin HuseynovLadenburg Thalmann & Co. | BuyInitiated€35.87 | 01/05/26 | 58706.81%Upside |
Best Analysts Covering Akari Therapeutics
Copying Sean Lee CFA's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -3.00% per trade.
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -21.92% per trade.
Copying Sean Lee CFA's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -26.57% per trade.
CLA1 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 5 | 4 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 4 | 5 | 4 | 2 |
In the current month, CLA1 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CLA1 average Analyst price target in the past 3 months is 22.87.
CLA1 Financial Forecast
CLA1 Earnings Forecast
Next quarter’s earnings estimate for CLA1 is EUR 0.00 with a range of ― to ―. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CLA1 Sales Forecast
Next quarter’s sales forecast for CLA1 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
